文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

气单胞菌属人类感染的临床表现、抗菌药物耐药性与治疗结局:一项14年回顾性研究及2例致死病例分离株的比较基因组学

Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of Aeromonas Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal Cases.
PubMed 文献 · Clin Infect Dis · 2024-01-01

该14年回顾性研究分析了105例气单胞菌感染患者及112株分离株,发现皮肤软组织感染、创伤感染、脓毒症、烧伤和腹腔感染常见,碳青霉烯类与哌拉西林-他唑巴坦耐药率高,治疗失败率为25.7%,脓毒性休克与医院获得性感染是治疗失败的预测因素。两例致死性达卡气单胞菌菌血症分离株均对黏菌素耐药并携带mcr-3基因。

要点

  • 皮肤软组织感染、创伤感染、脓毒症、烧伤和腹腔感染为常见表现。
  • 男性、年龄≥65岁、住院、烧伤及重症监护入住与复杂疾病相关。
  • 治疗失败率为25.7%,脓毒性休克和医院获得性感染为预测因素。

核心结论

  • 根据当地药敏谱制定经验性治疗可能有助于改善结局。
  • 先进诊断方法可能有助于鉴定具有重要临床意义的气单胞菌菌种。

研究设计与样本

  • 回顾性研究,纳入105例气单胞菌感染患者和112株分离株。
  • 对2例致死性达卡气单胞菌菌血症分离株(A和B)进行全基因组测序,并与腹泻分离株达卡气单胞菌SSU及环境分离株嗜水气单胞菌American Type Culture Collection_7966T比较毒力因子和耐药基因。

主要发现

  • 皮肤软组织感染、创伤性伤口感染、脓毒症、烧伤和腹腔感染常见;糖尿病、恶性肿瘤和肝硬化是常见合并症。
  • 男性、年龄≥65岁、住院、烧伤和重症监护入住与复杂疾病相关。
  • 对碳青霉烯类和哌拉西林-他唑巴坦的耐药率高。
  • 治疗失败率为25.7%;脓毒性休克和医院获得性感染是治疗失败的预测因素。
  • 所有4株分离株均携带多种广谱耐药基因,包括blaOXA、ampC、cphA和外排泵。

关键数值与推荐

  • 仅临床分离株同时携带极性和侧生鞭毛基因、多种表面黏附蛋白基因、3型和6型分泌系统及其效应物基因以及毒素基因(包括外毒素A)。
  • 分离株A和B均对黏菌素耐药并携带可移动黏菌素耐药-3(mcr-3)基因。

临床怎么用

  • 根据当地药敏谱制定经验性治疗可能有助于改善结局(作者认为)。
  • 先进诊断方法可能有助于鉴定具有重要临床意义的气单胞菌菌种(作者认为)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aeromonas virulence may not be entirely dependent on the host's immune status. Pathophysiologic determinants of disease progression and severity remain unclear. METHODS: One hundred five patients with Aeromonas infections and 112 isolates were identified, their clinical presentations and outcomes were analyzed, and their antimicrobial resistance (AMR) patterns were assessed. Two isolates (A and B) from fatal cases of Aeromonas dhakensis bacteremia were characterized using whole-genome sequencing. Virulence factor- and AMR-encoding genes from these isolates were compared with a well-characterized diarrheal isolate A. dhakensis SSU and environmental isolate Aeromonas hydrophila American Type Culture Collection_7966T. RESULTS: Skin and soft tissue infections, traumatic wound infections, sepsis, burns, and intraabdominal infections were common. Diabetes, malignancy, and cirrhosis were frequent comorbidities. Male sex, age ≥ 65 years, hospitalization, burns, and intensive care admission were associated with complicated disease. High rates of AMR to carbapenems and piperacillin-tazobactam were found. Treatment failure was observed in 25.7% of cases. Septic shock and hospital-acquired infections were predictors of treatment failure. All 4 isolates harbored assorted broad-spectrum AMR genes including blaOXA, ampC, cphA, and efflux pumps. Only clinical isolates possessed both polar and lateral flagellar genes, genes for various surface adhesion proteins, type 3 and 6 secretion systems and their effectors, and toxin genes, including exotoxin A. Both isolates A and B were resistant to colistin and harbored the mobile colistin resistance-3 (mcr-3) gene. CONCLUSIONS: Empirical therapy tailored to local antibiograms may facilitate favorable outcomes, while advanced diagnostic methods may aid in identifying correct Aeromonas spp. of significant clinical importance.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Pineda-Reyes R, Neil BH, Orndorff J, et al. Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of Aeromonas Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal Cases. Clin Infect Dis. 2024. PMID: 38759099. doi:10.1093/cid/ciae272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。